Lichens as a source of chemical compounds with anti-inflammatory activity

• Autorzy: Studzinska-Sroka E. , Dubino A.

Warianty tytułu

PL

Porosty jako źródło związków o działaniu przeciwzapalnym

• Języki publikacji: EN

Abstrakty

EN

Symptoms of inflammation accompany a number of diseases. In order to mitigate them, folk medicine has used a variety of medicinal substances, including herbs and mushrooms. Lichens are less known organisms, containing specific secondary metabolites with interesting biological properties. One of their biological actions is the anti-inflammatory activity that has been confirmed by in vitro and animal studies. It has been proven that compounds and extracts from lichens inhibit the enzymes involved in the inflammatory process. The following paper is a review of research on the little-known anti-inflammatory properties of lichens.

PL

Objawy zapalenia towarzyszą wielu jednostkom chorobowym. W celu ich łagodzenia medycyna ludowa wykorzystuje różnorodne substancje lecznicze, w tym zioła i grzyby. Porosty stanowią grupę organizmów mniej znanych, lecz zawierających specyficzne metabolity wtórne o ciekawych właściwościach biologicznych. Jednym z kierunków działania porostów, potwierdzonym badaniami w warunkach in vitro i na zwierzętach, jest aktywność przeciwzapalna. Dowiedziono, że związki i wyciągi z porostów działają m.in. poprzez hamowanie enzymów uczestniczących w przebiegu procesu zapalnego. Artykuł stanowi przegląd badań nad mało znanymi przeciwzapalnymi właściwościami porostów.

Słowa kluczowe

EN

lichen; lichen extract; source; chemical compound; antiinflammatory activity; biological activity

• Wydawca: -
• Czasopismo: Herba Polonica
• Rocznik: 2018
• Tom: 64
• Numer: 1
• Opis fizyczny: p.56-64,fig.,ref.

Twórcy

autor

Studzinska-Sroka E.

• Department of Pharmacognosy, Poznan University of Medical Sciences, Swiecickiego 4, 60-781 Poznan, Poland

autor

Dubino A.

• Department of Pharmacognosy, Poznan University of Medical Sciences, Swiecickiego 4, 60-781 Poznań, Poland

Bibliografia

• Dawid-Pać R. Fitoterapia schorzeń dermatologicznych. In: Nowak G., ed. Leki pochodzenia naturalnego. 1st ed. Poznań. Wydawnictwo Naukowe UMP, 2012:296-339.
• Studzińska-Sroka E, Galanty A, Bylka W. Atranorin – an interesting lichen secondary metabolite. Mini Rev Med Chem 2017; 17(17):1633-1645. doi: http://dx.doi.org/10.2174/1389557517666170425105727
• Xu M, Heidmarsson S, Olafsdottir ES, Buonfiglio R, Kogej T, Omarsdottir S. Secondary metabolites from cetrarioid lichens: Chemotaxonomy, biological activities and pharmaceutical potential. Phytomedicine 2016; 23(5):441-59. doi: http://dx.doi.org/10.1016/j.phymed.2016.02.012
• Studzińska E, Witkowska-Banaszczak E, Bylka W. Związki biologicznie czynne porostów. Herba Pol 2008; 54(1):79-88.
• Bugni TS, Andjelic CD, Pole AR, Rai P, Ireland CM, Barrows LR. Biologically active components of a Papua New Guinea analgesic and anti-in flammatory lichen preparation. Fitoterapia 2009; 80(5):270-3. doi: http://dx.doi.org/10.1016/j.fitote.2009.03.003
• Kumar S, Müller K. Lichen metabolites. 1. Inhibitory action against leukotriene B4. Biosynthesis by a non-redox mechanism. J Nat Prod 1999; 62(6):817-820.
• Ingolfsdotiir K, Gissurarson SR, Moller-Jakic B, Breu W, Wagner H. Inhibitory effects of the lichen metabolite lobaric acid on arachidonate metabolism in vitro. Phytomedicine 1996; 2(3):243-246.
• Melo MG, de Souza Araújo AA, Serafini MR, Carvalho LF, Bezerra MS, Ramos CS et al. Antiinflammatory and toxicity studies of atranorin extracted from Cladina kalbii Ahti in rodents. Braz J Pharm Sci 2011; 47(4):861-872. doi: http://dx.doi.org/10.1590/S1984-82502011000400024
• Umezawa H, Shibamoto N, Naganawa H, Ayukawa S, Matsuzaki M, Takeuchi T et al. Isolation of lecanoric acid, an inhibitor of histidine decarboxylase from a fungus. J Antibiot (Tokyo) 1974; 27(8):587-596
• Kumar SKC, Müller K. Depsides as non-redox inhibitors of leukotriene B4 biosynthesis and HaCaT cell growth. 1. Novel analogues of barbatic and diffractaic acid. Eur J Med Chem 1999; 35(4):1035-1042.
• Sankawa U, Shibuya M, Ebizuka Y Noguchi H, Kinoshita T, Iitaka Y et al. Depside as potent inhibitor of prostaglandin biosynthesis: a new active site model for fatty acid cyclooxygenase. Prostaglandins 1982; 24(1):21-34.
• Luz JG, Antonysamy S, Kuklish SL, Condon B, Lee MR, Allison D et al. Crystal structures of mPGES-1 inhibitor complexes form a basis for the rational design of potent analgesic and anti-inflammatory therapeutics. J Med Chem 2015; 58(11):4727-4737. doi: http://dx.doi.org/10.1021/acs.jmedchem.5b00330
• Bauera J, Waltenbergerb B, Nohac SM, Schusterc D, Rollingerb JM, Boustied J et al. Discovery of depsides and depsidones from lichen as potent inhibitors of microsomal prostaglandin E2 synthase-1 using pharmacophore models. Chem Med Chem 2012; 7(12):2077-2081. doi: http://dx.doi.org/10.1002/cmdc.201200345
• Oettl SK, Gerstmeier J, Khan SY, Wiechmann K, Bauer J, Atanasov AG et al. Imbricaric acid and perlatolic acid: multi-targeting anti-inflammatory depsides from Cetrelia monachorum. PLoS One 2013; 8(10). doi: http://dx.doi.org/10.1371/journal.pone.0076929
• Araújo AA, de Melo MG, Rabelo TK, Nunes PS, Santos SL, Serafini MR et al. Review of the biological properties and toxicity of usnic acid. Nat Prod Res 2015; 29(23):2167-80. doi: http://dx.doi.org/10.1080/14786419.2015.1007455
• Huang Z, Tao J, Ruan J, Li C, Zheng G. Antiinflammatory effects and mechanisms of usnic acid, a compound firstly isolated from lichen Parmelia saxatilis. J Med Plant Res 2014; 8(4):197-207. doi: http://dx.doi.org/10.5897/JMPR10.873
• Vijayakumar CS, Viswanathan S, Kannappa Reddy M, Parvathavarthini S, Kundu AB, Sukumar E. Anti-inflammatory activity of (+)-usnic acid. Fitoterapia 2000; 71(5):564-566.
• Su ZQ, Mo ZZ, Liao JB, Feng XX, Liang YZ, Zhang X et al. Usnic acid protects LPS-induced acute lung injury in mice through attenuating inflammatory responses and oxidative stress. Int Immunopharmacol 2014; 22(2):371-8. doi: http://dx.doi.org/10.1016/j.intimp.2014.06.043.
• Shrestha G, St Clair LL, O’Neill KL. The immunostimulating role of lichen polysaccharides: a review. Phytother Res 2015; 29(3):317-22. doi: http://dx.doi.org/10.1002/ptr.5251
• Omarsdottir S, Freysdottir J, Barsett H, Paulsen BS, Olafsdottir ES. Effects of lichen heteroglycans on proliferation and IL-10 secretion by rat spleen cells and IL-10 and TNF-alpha secretion by rat peritoneal macrophages in vitro. Phytomedicine 2005; 12(6-7):461-7.
• Omarsdottir S, Freysdottir J, Olafsdottir ES. Immunomodulating polysaccharides from the lichen Thamnolia vermicularis var. subuliformis. Phytomedicine 2007; 14(2-3):179-84. doi: http://dx.doi.org/10.1016/j.phymed.2006.11.012
• Molnár K, Farkas E. Current results on biological activities of lichen secondary metabolites: a review. Z Naturforsch C 2010; 65(3-4):157-173. doi: http://dx.doi.org/10.1515/znc-2010-3-401
• Güvenç A, Küpeli Akkol E, Süntar I, Keleş H, Yıldız S, Calış I. Biological activities of Pseudevernia furfuracea (L.) Zopf extracts and isolation of the active compounds. J Ethnopharmacol 2012; 144(3):726-734. doi: http://dx.doi.org/10.1016/j.jep.2012.10.021
• Jain AP, Bhandrkar S, Rai G, Yadav AK, Lodhi S. Evaluation of Parmotrema reticulatum Taylor for antibacterial and antiinflammatory activities. Indian J Pharm Sci 2016; 78(1):94-102.